Nicotinamide Mononucleotide (NMN) Market Size ($ 296.05 Billion by 2031 at CAGR of 7.49% CAGR) - which is Booming Strong Growth in the Globe till 2031 PUNE, Sept. 20, 2023 (GLOBE NEWSWIRE) -- “Nicotinamide Mononucleotide (NMN) Market” with analysis of such parameters i.e. industry growth drivers, supply and demand, risks, market attractiveness,...

Popular anti-aging ingredient used by Harvard Professor has landed in New Zealand AUCKLAND, New Zealand, Sept. 25, 2022 (GLOBE NEWSWIRE) -- New Zealand health company ‘SRW Laboratories’ have introduced a stabilised form of high purity NMN (Nicotinamide Mononucleotide) to their...

Nicotinamide Mononucleotide (NMN) Market will Turn over USD 251.2 to Revenue to Cross USD 953 million in 2022 to 2028 Research by Business Opportunities, Top Companies, opportunities planning, Market-specific challenges PUNE, Aug. 19, 2022 (GLOBE NEWSWIRE) -- Global "Nicotinamide Mononucleotide (NMN) Market" research report focus on overall information that can help to take decisions on current market situation....

Blue California Commercializes Nicotinamide Mononucleotide (NMN) for Supporting an Increased Healthspan Rancho Santa Margarita, Calif., July 20, 2021 (GLOBE NEWSWIRE) -- Blue California joins with the innovative Massachusetts-based biotech company Conagen to announce the commercialization of...

Effepharm Announced Acquisitions and New R&D Center Establishment SHANGHAI, China, Dec. 12, 2019 (GLOBE NEWSWIRE) -- Effepharm announce that they acquired two bio-pharmaceutical companies recently, named Dendrimer Co. and Folvo Co., the acquisition has enhanced...